Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B Cell Response to Inactivated Influenza Vaccine in Healthy Adults and Children
NCT03328325Phase 4Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2017
- Primary completion
- Feb 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2017; status: terminated.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03328325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03328325.